… Abstract In the 5 years since granulocyte-macrophage colony-stimulating factor (GMCSF)
was first tested clinically, a number of different strategies for its use have been evaluated in …

… that GMCSF decreases … tumor control. The purpose of this article is to discuss current and
future applications of yeast-derived GM-CSF and nursing practice issues in the administration …

… treatment of oral mucositis. Clinical data concerning the topical use of granulocyte-macrophage
colony-stimulating-factor (GM-CSF… radiochemotherapy for advanced cancer of the head …

… Granulocyte–macrophage colony-stimulating factor (GM-CSF) is often used to treat … In
1996, the Food and Drug Administration approved GM-CSF for treatment for leucopenia …

… as granulocyte-macrophage-colony stimulating factor (GM-CSF), G-CSF and stem cell factor
(SCF) in non-small-cell lung cancer … cancer patients in comparison with the control group. …

… On the one hand, it was shown that prostate cancer cells secreted GM-CSF and expressed
… Regulation of dendritic cell development by GM-CSF: molecular control and implications for …

… of GM-CSF in the control of fungal or protozoal disease and to take advantage of anti-tumor …
with infection, cancer and/or cancer chemotherapy, a role for GMCSF as a systemic immune …

… granulocyte–macrophage-CSF (GM-CSF) have now been used to increase dangerously
low white blood cell levels in many millions of cancer … to cancer patients who have treatment-…

… are treated with GM-CSF to correct the neutropenia following cancer chemotherapy can suffer
… In fact, administration of anti-GM-CSF antibody was found to reduce the protective immune …

… In concert with other colony-stimulating factors, GM-CSF … patients can be induced with GM-CSF
to differentiate in vitro although … cancer cells at physiological concentrations of GM-CSF is …